RNUGF (ReNeuron Group) Additional Paid-In Capital : $190.87 Mil(As of Sep. 2023)

View and export this data going back to 2006. Start your Free Trial

What is ReNeuron Group Additional Paid-In Capital?

ReNeuron Group's quarterly additional paid-in capital increased from Sep. 2022 ($174.65 Mil) to Mar. 2023 ($187.16 Mil) and increased from Mar. 2023 ($187.16 Mil) to Sep. 2023 ($190.87 Mil).

ReNeuron Group's annual additional paid-in capital declined from Mar. 2021 ($213.87 Mil) to Mar. 2022 ($203.19 Mil) and declined from Mar. 2022 ($203.19 Mil) to Mar. 2023 ($187.16 Mil).

ReNeuron Group Additional Paid-In Capital Historical Data

The historical data trend for ReNeuron Group's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group Additional Paid-In Capital Chart

ReNeuron Group Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Additional Paid-In Capital

Get a 7-Day Free Trial

181.82

171.02

213.87

203.19

187.16

ReNeuron Group Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Additional Paid-In Capital	Get a 7-Day Free Trial															211.84	203.19	174.65	187.16	190.87

ReNeuron Group Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

ReNeuron Group Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

ReNeuron Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (OTCPK:RNUGF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY

Website

https://www.reneuron.com

ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.